Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report

Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report

Abstract Background Anti-epidermal growth factor receptor (EGFR) antibody is widely used for the treatment of patients with metastatic colorectal cancer. Hypomagnesemia is a comparatively frequent adverse event of this drug, which is likely overlooked because it occurs later in treatment without sym...

Full description

Bibliographic Details
Main Authors: Taro Fukui, Koichi Suzuki, Sawako Tamaki, Iku Abe, Yuhei Endo, Hideki Ishikawa, Nao Kakizawa, Fumiaki Watanabe, Masaaki Saito, Shingo Tsujinaka, Kazushige Futsuhara, Yasuyuki Miyakura, Hiroshi Noda, Toshiki Rikiyama
Format: Article
Language:English
Published: SpringerOpen 2019-10-01
Series:Surgical Case Reports
Subjects:
Temporary loss of consciousness
Cetuximab
Serum magnesium
Colon cancer
Online Access:http://link.springer.com/article/10.1186/s40792-019-0707-5

Internet

http://link.springer.com/article/10.1186/s40792-019-0707-5

Similar Items